Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,600 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 November 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 216 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 251 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is I  [Clear All Filters]
2020
R. Ma, Cecil, E., Bottle, A., French, R., and Saxena, S., Impact of a pay-for-performance scheme for long-acting reversible contraceptive (LARC) advice on contraceptive uptake and abortion in British primary care: An interrupted time series study, PLoS Med, vol. 17, p. e1003333, 2020.
C. S. Cabrera, Lee, A. S., Olsson, M., Schnecke, V., Westman, K., Lind, M., Greasley, P. J., and Skrtic, S., Impact of CKD Progression on Cardiovascular Disease Risk in a Contemporary UK Cohort of Individuals With Diabetes, Kidney Int Rep, vol. 5, pp. 1651-1660, 2020.
A. Pate, Emsley, R., and Van Staa, T., Impact of lowering the risk threshold for statin treatment on statin prescribing: a descriptive study in English primary care, Br J Gen Pract, vol. 70, pp. e765-e771, 2020.
A. Pate, Emsley, R., Sperrin, M., Martin, G. P., and Van Staa, T., Impact of sample size on the stability of risk scores from clinical prediction models: a case study in cardiovascular disease, Diagn Progn Res, vol. 4, p. 14, 2020.
A. Pate, Elliott, R. A., Gkountouras, G., Thompson, A., Emsley, R., and Van Staa, T., The impact of statin discontinuation and restarting rates on the optimal time to initiate statins and on the number of cardiovascular events prevented, Pharmacoepidemiol Drug Saf, 2020.
J. Tazare, Smeeth, L., Evans, S. J. W., Williamson, E., and Douglas, I. J., Implementing high-dimensional propensity score principles to improve confounder adjustment in UK electronic health records, Pharmacoepidemiol Drug Saf, 2020.
F. Tyrer, Zaccardi, F., Khunti, K., and Morriss, R., Incidence of Depression and First-Line Antidepressant Therapy in People with Obesity and Depression in Primary Care, Obesity (Silver Spring), vol. 28, pp. 977-984, 2020.
C. V. Chalitsios, McKeever, T. M., and Shaw, D. E., Incidence of osteoporosis and fragility fractures in asthma: a UK population-based matched cohort study, Eur Respir J, 2020.
L. Grønbaek, Otete, H., Ban, L., Crooks, C., Card, T., Jepsen, P., and West, J., Incidence, prevalence, and mortality of autoimmune hepatitis in England 1997-2015. A population-based cohort study, Liver Int, 2020.
M. S. M. Persson, Harman, K. E., Vinogradova, Y., Langan, S. M., Hippisley-Cox, J., Thomas, K. S., and Gran, S., Incidence, prevalence, and mortality of bullous pemphigoid in England 1998-2017: a population-based cohort study, Br J Dermatol, 2020.
O. B. Esan, Perera, R., McCarthy, N., Violato, M., and Fanshawe, T. R., Incidence, risk factors, and health service burden of sequelae of campylobacter and non-typhoidal salmonella infections in England, 2000-2015: A retrospective cohort study using linked electronic health records, J Infect, 2020.
R. Persson, Lee, S., Yood, M. U., Wagner, M., Minton, N., Niemcryk, S., Lindholm, A., Evans, A., and Jick, S., Incident cardiovascular disease in patients diagnosed with multiple sclerosis: A multi-database study, Mult Scler Relat Disord, vol. 37, p. 101423, 2020.
R. Persson, Lee, S., Yood, M. U., Mc, M. R. Wagner, Minton, N., Niemcryk, S., Lindholm, A., Evans, A. M., and Jick, S., Incident depression in patients diagnosed with multiple sclerosis: a multi-database study, Eur J Neurol, 2020.
C. Zecca, Disanto, G., Sacco, R., MacLachlan, S., Kuhle, J., Ramagopalan, S. V., and Gobbi, C., Increasing cancer risk over calendar year in people with multiple sclerosis: a case-control study, J Neurol, 2020.
J. Rouette, Yin, H., Yu, O. H. Y., Bouganim, N., Platt, R. W., and Azoulay, L., Incretin-based drugs and risk of lung cancer among individuals with type 2 diabetes, Diabet Med, 2020.
R. Persson, Lee, S., M. Yood, U., Mc, C. M. Wagner, Minton, N., Niemcryk, S., Lindholm, A., Evans, A. M., and Jick, S. S., Infections in patients diagnosed with multiple sclerosis: A multi-database study, Mult Scler Relat Disord, vol. 41, p. 101982, 2020.
J. P. A. Houwen, Egberts, A. C. G., de Boer, A., van Maarseveen, E. M., Houwen, R. H. J., and Lalmohamed, A., Influence of allopurinol on thiopurine associated toxicity: A retrospective population-based cohort study, Br J Clin Pharmacol, 2020.
C. S. Osam, Pierce, M., Hope, H., Ashcroft, D. M., and Abel, K. M., The influence of maternal mental illness on vaccination uptake in children: a UK population-based cohort study, Eur J Epidemiol, 2020.
L. E. Clarson, Bajpai, R., Whittle, R., Belcher, J., A. Sultan, A., Kwok, C. S., Welsh, V., Mamas, M., and Mallen, C. D., Interstitial lung disease is a risk factor for ischaemic heart disease and myocardial infarction, Heart, 2020.
C. Martinez, Wallenhorst, C., Rietbrock, S., and Freedman, B., Ischemic Stroke and Transient Ischemic Attack Risk Following Vitamin K Antagonist Cessation in Newly Diagnosed Atrial Fibrillation: A Cohort Study, J Am Heart Assoc, vol. 9, p. e014376, 2020.
2019
H. Carreira, Williams, R., Strongman, H., and Bhaskaran, K., Identification of mental health and quality of life outcomes in primary care databases in the UK: a systematic review, BMJ Open, vol. 9, p. e029227, 2019.
B. Carter, C. Bennett, V., Bethel, J., Jones, H. M., Wang, T., and Kemp, A., Identifying cerebral palsy from routinely-collected data in England and Wales, Clin Epidemiol, vol. 11, pp. 457-468, 2019.
M. Pikoula, Quint, J. K., Nissen, F., Hemingway, H., Smeeth, L., and Denaxas, S., Identifying clinically important COPD sub-types using data-driven approaches in primary care population based electronic health records, BMC Med Inform Decis Mak, vol. 19, p. 86, 2019.
B. M. Shields, Hattersley, A. T., and Farmer, A. J., Identifying routine clinical predictors of non-adherence to second line therapies in Type 2 diabetes: a retrospective cohort analysis in a large primary care database, Diabetes Obes Metab, 2019.
E. Ford, Rooney, P., Oliver, S., Hoile, R., Hurley, P., Banerjee, S., van Marwijk, H., and Cassell, J., Identifying undetected dementia in UK primary care patients: a retrospective case-control study comparing machine-learning and standard epidemiological approaches, BMC Med Inform Decis Mak, vol. 19, p. 248, 2019.
P. Tammes, Payne, R. A., Salisbury, C., Chalder, M., Purdy, S., and Morris, R. W., The impact of a named GP scheme on continuity of care and emergency hospital admission: a cohort study among older patients in England, 2012-2016, BMJ Open, vol. 9, p. e029103, 2019.
V. Allan, Sammon, C. J., McDonald, L., Mehmud, F., Alikhan, R., and Ramagopalan, S. V., Impact of atrial fibrillation awareness campaigns: interrupted time series using the Clinical Practice Research Datalink, Future Cardiol, 2019.
N. Al-Attar, Johnston, S., Jamous, N., Mistry, S., Ghosh, E., Gangoli, G., Danker, W., Etter, K., and Ammann, E., Impact of bleeding complications on length of stay and critical care utilization in cardiac surgery patients in England, J Cardiothorac Surg, vol. 14, p. 64, 2019.
E. Burn, Edwards, C. J., Murray, D. W., Silman, A., Cooper, C., Arden, N. K., Prieto-Alhambra, D., and Pinedo-Villanueva, R., The impact of bmi and smoking on risk of revision following knee and hip replacement surgery: evidence from routinely collected data, Osteoarthritis Cartilage, 2019.
D. Z. I. Cherney, Repetto, E., Wheeler, D. C., Arnold, S. V., MacLachlan, S., Hunt, P. R., Chen, H., Vora, J., and Kosiborod, M., Impact of Cardio-Renal-Metabolic Comorbidities on Cardiovascular Outcomes and Mortality in Type 2 Diabetes Mellitus, Am J Nephrol, pp. 1-9, 2019.
J. Ride, Kasteridis, P., Gutacker, N., Doran, T., Rice, N., Gravelle, H., Kendrick, T., Mason, A., Goddard, M., Siddiqi, N., Gilbody, S., Williams, R., Aylott, L., Dare, C., and Jacobs, R., Impact of family practice continuity of care on unplanned hospital use for people with serious mental illness, Health Serv Res, 2019.
L. Han, Clegg, A., Doran, T., and Fraser, L., The impact of frailty on healthcare resource use: a longitudinal analysis using the Clinical Practice Research Datalink in England, Age Ageing, 2019.
C. D. Steer, Macleod, J., Tilling, K., Lim, A. G., Marsden, J., Millar, T., Strang, J., Telfer, M., Whitaker, H., Vickerman, P., and Hickman, M., The impact of opiate substitution treatment on mortality risk in drug addicts: a natural experiment study, Health Services and Delivery Research, vol. 7, no. 3, 2019.
J. Blackwell, Saxena, S., Alexakis, C., Bottle, A., Cecil, E., Majeed, A., and Pollok, R. C., The impact of smoking and smoking cessation on disease outcomes in ulcerative colitis: a nationwide population-based study, Aliment Pharmacol Ther, vol. 50, pp. 556-567, 2019.
J. T. H. Nielen, Dagnelie, P. C., Boonen, A., Klungel, O., van den Bemt, B., and de Vries, F., Impact of the definition of osteoarthritis and of the timing of its onset on the association between type 2 diabetes mellitus and osteoarthritis: Clinical Practice Research Datalink, Diabetes Res Clin Pract, vol. 148, pp. 240-248, 2019.
H. C. Patel, Hayward, C., Patel, K. S., Claggett, B., Vazir, A., and Cowie, M. R., Impact on survival of combination inhalers in patients with COPD at high risk of cardiovascular events, Int J Cardiol, 2019.
R. Gafoor, Charlton, J., Ravindrarajah, R., and Gulliford, M. C., Importance of Frailty for Association of Antipsychotic Drug Use with Risk of Fracture: Cohort Study Using Electronic Health Records, J Am Med Dir Assoc, 2019.
C. I. Bloom, Walker, S., and Quint, J. K., Inadequate specialist care referrals for high-risk asthma patients in the UK: an adult population-based cohort 2006-2017, J Asthma, pp. 1-7, 2019.
L. Ibanez, Sabate, M., Vidal, X., Ballarin, E., Rottenkolber, M., Schmiedl, S., Heeke, A., Huerta, C., E. Merino, M., Montero, D., Leon-Munoz, L. M., Gasse, C., Moore, N., Droz, C., Lassalle, R., Aakjaer, M., Andersen, M., De Bruin, M. L., Groenwold, R., van den Ham, R., Souverein, P., Klungel, O., and Gardarsdottir, H., Incidence of Direct Oral Anticoagulant use in patients with non-valvular atrial fibrillation and characteristics of users in six European countries (2008-2015): A cross-national drug utilization study, Br J Clin Pharmacol, 2019.
V. Cairns, Wallenhorst, C., Rietbrock, S., and Martinez, C., Incidence of Lyme disease in the UK: a population-based cohort study, BMJ Open, vol. 9, p. e025916, 2019.
K. Davies, Johnson, E. L., Hollen, L., Jones, H. M., Lyttle, M. D., Maguire, S., and Kemp, A. M., Incidence of medically attended paediatric burns across the UK, Inj Prev, 2019.
N. E. O'Connell, Smith, K. J., Peterson, M. D., Ryan, N., Liverani, S., Anokye, N., Victor, C., and Ryan, J. M., Incidence of osteoarthritis, osteoporosis and inflammatory musculoskeletal diseases in adults with cerebral palsy: A population-based cohort study, Bone, vol. 125, pp. 30-35, 2019.
L. Wei, Lai, E. C., Kao-Yang, Y. H., Walker, B. R., MacDonald, T. M., and Andrew, R., Incidence of type 2 diabetes mellitus in men receiving steroid 5alpha-reductase inhibitors: population based cohort study, Bmj, vol. 365, p. l1204, 2019.
A. Gayle, Dickinson, S., Poole, C., Pang, M., Fauconnot, O., and Quint, J. K., Incidence of type II diabetes in chronic obstructive pulmonary disease: a nested case-control study, NPJ Prim Care Respir Med, vol. 29, p. 28, 2019.
T. S. Field, Weijs, B., Curcio, A., Giustozzi, M., Sudikas, S., Katholing, A., Wallenhorst, C., Weitz, J. I., Cohen, A. T., and Martinez, C., Incident Atrial Fibrillation, Dementia and the Role of Anticoagulation: A Population-Based Cohort Study, Thromb Haemost, 2019.
H. R. Whittaker, Mullerova, H., Jarvis, D., Barnes, N. C., Jones, P. W., Compton, C. H., Kiddle, S. J., and Quint, J. K., Inhaled corticosteroids, blood eosinophils, and FEV1 decline in patients with COPD in a large UK primary health care setting, Int J Chron Obstruct Pulmon Dis, vol. 14, pp. 1063-1073, 2019.
[Page last reviewed 6 November 2020]